Company / Shares Outstanding
Eloxx Pharmaceuticals, Inc. Shares Outstanding History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
3.1M
FY2025
5-year range
2.3M / 18.8M
FY2021-FY2025
Trend
-83.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 13846361.00 to 3143390.00 over the past 10 years.
Based on SEC 10-K filings.
3143390.00 in FY2025 with a 10-year CAGR of -13.8%.
Improved from 13846361.00 to 3143390.00 over the past 10 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -13.8%
Key checks
Key Insights
- In FY2025, shares outstanding decreased 83.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.1M | -83.2% |
| FY2016 | 18.8M | +35.4% |
| FY2015 | 13.8M | +509.4% |
| FY2014 | 2.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026